Loading stock data…
$6.79+0.00 (+0.07%)
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system.
CapsoVision, Inc. in the Healthcare sector is trading at $6.79 with a market capitalization of $326M. Wall Street consensus targets $9.50 (2 analysts), implying a +40.0% move over the next 12 months. The stock is currently 56% below its 52-week high of $15.37, remaining 5.4% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the safe zone. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.64M↑ | $2.79M↓ | $3.92M↑ | $3.54M↑ | $3.31M |
| Gross Profit | $1.87M↑ | $1.33M↓ | $1.95M↑ | $1.91M↑ | $1.81M |
| Operating Income | -$7.58M↓ | -$7.09M↑ | -$7.46M↑ | -$8.02M↓ | -$4.65M |
| Net Income | -$7.48M↓ | -$7.03M↑ | -$7.39M↑ | -$7.92M↓ | -$4.63M |
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of t...